Literature DB >> 24262658

Chronic mTOR activation promotes cell survival in Merkel cell carcinoma.

Zhenyu Lin1,2, Amelia McDermott3, Lijian Shao4, Aarthi Kannan1, Michael Morgan5, Brendan C Stack6, Mauricio Moreno6, Daniel A Davis1, Lynn A Cornelius7, Ling Gao1.   

Abstract

Merkel cell carcinoma (MCC) is an aggressive skin cancer with rising incidence. In this study, we demonstrate that mTOR activation and suppressed autophagy is common in MCCs. mTOR inhibition in two primary human MCC cell lines induces autophagy and cell death that is independent of caspase activation but can be attenuated by autophagy inhibition. This is the first study to evaluate mTOR and autophagy in MCC. Our data suggests a potential role of autophagic cell death upon mTOR inhibition and thus uncovers a previously underappreciated role of mTOR signaling and cell survival, and merits further studies for potential therapeutic targets. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Autophagy; Cell death; Merkel cell carcinoma; mTOR inhibitor; mTOR pathway

Mesh:

Substances:

Year:  2013        PMID: 24262658      PMCID: PMC4080622          DOI: 10.1016/j.canlet.2013.11.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  51 in total

Review 1.  Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.

Authors:  Seth A Wander; Bryan T Hennessy; Joyce M Slingerland
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

2.  Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival.

Authors:  Mohamed Elgendy; Clare Sheridan; Gabriela Brumatti; Seamus J Martin
Journal:  Mol Cell       Date:  2011-02-25       Impact factor: 17.970

Review 3.  Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.

Authors:  Nicole F Villeneuve; Alexandria Lau; Donna D Zhang
Journal:  Antioxid Redox Signal       Date:  2010-08-14       Impact factor: 8.401

4.  Autophagy in pancreatic cancer: an emerging mechanism of cell death.

Authors:  Nameeta Mujumdar; Ashok K Saluja
Journal:  Autophagy       Date:  2010-10-16       Impact factor: 16.016

5.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis.

Authors:  Jessie Yanxiang Guo; Hsin-Yi Chen; Robin Mathew; Jing Fan; Anne M Strohecker; Gizem Karsli-Uzunbas; Jurre J Kamphorst; Guanghua Chen; Johanna M S Lemons; Vassiliki Karantza; Hilary A Coller; Robert S Dipaola; Celine Gelinas; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2011-02-11       Impact factor: 11.361

6.  Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.

Authors:  Masahiro Shuda; Hyun Jin Kwun; Huichen Feng; Yuan Chang; Patrick S Moore
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

7.  Merkel's cell carcinoma in organ recipients: report of 41 cases.

Authors:  I Penn; M R First
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

8.  Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria.

Authors:  E Wirawan; L Vande Walle; K Kersse; S Cornelis; S Claerhout; I Vanoverberghe; R Roelandt; R De Rycke; J Verspurten; W Declercq; P Agostinis; T Vanden Berghe; S Lippens; P Vandenabeele
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

9.  Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.

Authors:  Chun-Fang Zou; Luoqi Jia; Hongyan Jin; Ming Yao; Naiqing Zhao; Jin Huan; Zhen Lu; Robert C Bast; Youji Feng; Yinhua Yu
Journal:  BMC Cancer       Date:  2011-01-19       Impact factor: 4.430

10.  LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1.

Authors:  Shiqiao Ye; Tristan W Fowler; Nathan J Pavlos; Pei Ying Ng; Kai Liang; Yunfeng Feng; Minghao Zheng; Richard Kurten; Stavros C Manolagas; Haibo Zhao
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

View more
  18 in total

Review 1.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

2.  BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo.

Authors:  Qiang Shao; Aarthi Kannan; Zhenyu Lin; Brendan C Stack; James Y Suen; Ling Gao
Journal:  Cancer Res       Date:  2014-10-02       Impact factor: 12.701

3.  Merkel cell carcinoma of the lower leg with retroperitoneal GIST: a very rare association.

Authors:  Uwe Wollina; Gesina Hansel; Felicitas Zimmermann; Jacqueline Schönlebe; Andreas Nowak
Journal:  Wien Klin Wochenschr       Date:  2015-05-06       Impact factor: 1.704

4.  Effect of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against human Merkel cell carcinoma MKL-1 cells.

Authors:  Zhenyu Lin; Hong Mei; Jiquan Fan; Zhongyuan Yin; Gang Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

5.  Alternative splicing of S6K1 promotes non-small cell lung cancer survival.

Authors:  Hong Mei; Ye Wang; Jiquan Fan; Zhenyu Lin
Journal:  Tumour Biol       Date:  2016-07-27

6.  Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?

Authors:  Guilherme Rabinowits
Journal:  Cancers (Basel)       Date:  2014-05-16       Impact factor: 6.639

7.  Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.

Authors:  Deepanwita Sengupta; Aarthi Kannan; Malan Kern; Mauricio A Moreno; Emre Vural; Brendan Stack; James Y Suen; Alan J Tackett; Ling Gao
Journal:  Epigenetics       Date:  2015-05-05       Impact factor: 4.528

8.  A Proteomic Study of Human Merkel Cell Carcinoma.

Authors:  Qiang Shao; Stephanie D Byrum; Linley E Moreland; Samuel G Mackintosh; Aarthi Kannan; Zhenyu Lin; Michael Morgan; Brendan C Stack; Lynn A Cornelius; Alan J Tackett; Ling Gao
Journal:  J Proteomics Bioinform       Date:  2013-11-25

9.  The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.

Authors:  Shuo Chen; Dan-Dan Wu; Xiu-Bo Sang; Li-Li Wang; Zhi-Hong Zong; Kai-Xuan Sun; Bo-Liang Liu; Yang Zhao
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

10.  Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.

Authors:  Aarthi Kannan; Zhenyu Lin; Qiang Shao; Stephanie Zhao; Bin Fang; Mauricio A Moreno; Emre Vural; Brendan C Stack; James Y Suen; Krishnaswamy Kannan; Ling Gao
Journal:  Oncotarget       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.